The use of lactobacillus reuteri as an adjunct in the treatment of children with newly diagnosed asthma in a tertiary hospital in the Philippines
10.35460/2546-1621.2019-0079
- Author:
Jose Carlo Miguel M. Villanueva
1
,
2
Author Information
1. Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Santo Tomas, Españ
2. a, Manila, Philippines, 1015
- Publication Type:Observational Study
- MeSH:
Limosilactobacillus reuteri;
Probiotics;
Asthma;
Child
- From:
Journal of Medicine University of Santo Tomas
2023;7(1):1080-1089
- CountryPhilippines
- Language:English
-
Abstract:
Rationale:Probiotics are live microorganisms that exert beneficial effects on the host, including a reduction of allergic disease symptoms. Lactobacillus reuteri in particular was shown to attenuate the allergic airway, and when used as an adjunct in the treatment of asthma in children, resulted in decreased fractional exhaled nitric oxide and interleukin levels when compared to placebo. However, insufficient information is available regarding the significance of L. reuteri as an adjunct in the treatment of allergic disorders, particularly in allergic airway disease.
- Full text:jmust 4.pdf
